Garlon Polyfab reports net loss of ₹0.61 lakh in Q3FY25
Garlon Polyfab Industries Limited reported a net loss of ₹0.61 lakh for Q3FY25 ended December 31, 2024, with no operational income. The Board approved the unaudited results on February 14, 2025, revealing finance costs of ₹0.25 lakh and other expenses of ₹0.61 lakh for the quarter.

*this image is generated using AI for illustrative purposes only.
Garlon Polyfab Industries Limited reported a net loss of ₹0.61 lakh for the quarter ended December 31, 2024, with no income from operations recorded during the period. The Board of Directors approved the unaudited financial results for Q3FY25 at a meeting held on February 14, 2025.
The company's financial statement shows zero income from operations and other income for the quarter. Total expenses were reported at -₹0.61 lakh, primarily driven by finance costs of ₹0.25 lakh and other expenses amounting to ₹0.61 lakh. Changes in inventories of finished goods and work-in-progress stood at ₹0.36 lakh.
For the nine months ended December 31, 2024, the company recorded a net loss of ₹1.75 lakh. Finance costs for the nine-month period aggregated to ₹0.67 lakh, while other expenses totaled ₹1.75 lakh. The paid-up equity share capital remained unchanged at ₹4.61 lakh.
The Basic Earnings Per Share (EPS) for the quarter ended December 31, 2024, was reported at (0.13). For the nine months ended December 31, 2024, the EPS stood at (0.00). The comparative figures for the previous year were not reviewed by the auditors.
D.C. Shukla & Co., Chartered Accountants, conducted a limited review of the standalone financial results. The auditors noted that the comparative figures, including reconciliation to the Total Comprehensive Income, were furnished by the management and not reviewed by them.
What strategic initiatives does the company plan to implement to resume operations and generate income in the upcoming quarters?
How does the company intend to manage and reduce its finance costs given the current lack of operational revenue?
Are there any pending corporate actions or capital restructuring plans being considered by the Board to address the persistent losses?

































